The pharmaceutical industry has encountered previously unheard-of difficulties in recent years. The average cost of pharmaceuticals in the US has increased by 24% over the last three years as a result of safety concerns, problems with certain prescriptions, and competition from both non-generic and generic drugs. Prescription costs for those with private insurance decreased by 4% as a result between 2010 and 2013.Developing countries with similar challenges include Brazil, India, and China. Developing a series of vaccines with medicinal properties is one such treatment.Antibiotics are necessary to treat bacterial infections and preserve population and individual health over the long run. On the other hand, antibiotic-resistant bacterial infections are a global health concern.